Introducing Ciraplex® ULTRA Ultrasensitive Assays Combining the Power of Multiplexing with Ultrasensitivity
Ciraplex® ULTRA Ultrasensitive Assays with femtogram/ml (fg/ml) levels of detection address multiple biomarkers in a wide range of therapeutic areas. These kits offer enhanced sensitivity and an extended dynamic range providing quantification below standard detection limits. As well, intuitive Cira™ software streamlines the data management process providing exceptional data control.
The Cira™ immunoassay platform was specifically designed by a team of Aushon engineers and biologists to offer accurate multiplex biomarker analysis with simplicity and savings in mind. The Cira™ platform combines the accuracy and precision of ELISA, the sensitivity of chemiluminescence, and the throughput and affordability of multiplexing. The circular Ciraplex® format (patent-pending) offers enhanced accuracy and precision versus traditional protein array configurations. The Aushon menu features key biomarkers in a wide range of therapeutic areas being used to enhance knowledge and improve decision-making in translational medicine.
Cira Confidence: Ultrasensitivity Multiplexing Intuitive Simplicity Savings
Validation Report for
the Ciraplex® Human Cytokine 9-Plex Array:
IFNγ, IL-1α, IL-1β, IL-4, IL-6 IL-8, IL-10, IL-12p70,
TNFα (Active Trimer)
Oct 20, 2016 — Dr. Andrew Nixon scheduled to present Ultra-sensitive Protein Multiplex Arrays - Going Where No One Has Gone Before at the 2016 World CDx Conference. Read More
Oct 18-21, 2016 — Aushon sponsors 7th Annual World CDx Summit 2016 in Boston. Read More
Sep 25-27, 2016 — Aushon sponsors 6th Global Reverse Phase Protein Array Workshop in Tübingen, Germany. Read More
May 19, 2016 — Genome Web Publishes Article on Aushon's move into the ultrasensitive immunoassay space through the development of a series of cytokine assays that can achieve sensitivity in the femtogram per ml range. Read More
May 17, 2016 — Dr. Maribeth Raines presents Comparison of Human
IL-6 Detection Across Multiple Immunoassay Platforms at the 2016 Biomarker World Congress. Read More